Back
Aptevo Therapeutics, Inc. Stock Predictions
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
36
APVO
Aptevo Therapeutics, Inc.
Last Price:
$1.40
Seasonality Move:
-19.09%
7 Day Trial
ALL ACCESS PASS
$
7
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiAptevo Therapeutics, Inc. Stock Forecast
-
Is Aptevo Therapeutics, Inc. Stock Undervalued?The current Aptevo Therapeutics, Inc. [APVO] share price is $1.39. The Score for APVO is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
APVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Aptevo Therapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
Aptevo Therapeutics, Inc. Stock Rating
Data Unavailable
Aptevo Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
aptevotherapeutics.com
52-Week Data
52-Week High:
298.00
52-Week Low:
1.04
Prediction Charts
Market Cap:
4.5M
Price in USD:
1.39
Volume:
546.1K
Beta:
4.43
Technical Analysis
SMA50:
1.45
SMA100:
1.79
SMA200:
11.43
52-Wk Change:
-99.31%
Stock Predictions
-
Is Aptevo Therapeutics, Inc. stock public?Yes, Aptevo Therapeutics, Inc. is a publicly traded company.
-
What is the Aptevo Therapeutics, Inc. stock quote today?The Aptevo Therapeutics, Inc. stock price is 1.39 USD today.
-
How to buy Aptevo Therapeutics, Inc. stock online?You can buy Aptevo Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 1.41 | 1.41 | 1.43 | 1.38 |
| Nov-17 | 1.40 | 1.37 | 1.43 | 1.35 |
| Nov-18 | 1.34 | 1.32 | 1.35 | 1.27 |
| Nov-19 | 1.30 | 1.22 | 1.31 | 1.21 |
| Nov-20 | 1.25 | 1.08 | 1.25 | 1.07 |
| Nov-21 | 1.10 | 1.13 | 1.14 | 1.04 |
| Nov-24 | 1.14 | 1.18 | 1.19 | 1.12 |
| Nov-25 | 1.19 | 1.20 | 1.22 | 1.15 |
| Nov-26 | 1.23 | 1.28 | 1.29 | 1.21 |
| Nov-28 | 1.30 | 1.38 | 1.39 | 1.29 |
| Dec-1 | 1.36 | 1.32 | 1.42 | 1.30 |
| Dec-2 | 1.31 | 1.27 | 1.34 | 1.27 |
| Dec-3 | 1.29 | 1.38 | 1.38 | 1.26 |
| Dec-4 | 1.37 | 1.39 | 1.41 | 1.34 |
Aptevo Therapeutics, Inc. Earnings
Data Unavailable
Aptevo Therapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1,713.82 per share, and an increase next year of $3.78 per share.
* Aptevo Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.